Article Information
PubMed
Published By
History
- Received August 4, 2020
- Revision received December 23, 2020
- Accepted January 1, 2021
- Published online February 25, 2021.
Copyright & Usage
Copyright © 2021 Pelisch et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- Nicolas Pelisch1,3,
- Jose Rosas Almanza1,3,
- Kyle E. Stehlik1,3,
- Brandy V. Aperi1,3 and
- Antje Kroner1,2,3
- 1Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, WI 53226
- 2Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI 53226
- 3Clement J. Zablocki Veterans Affairs Medical Center, Milwaukee, WI 53295
- Correspondence should be addressed to Antje Kroner at akroner{at}mcw.edu.
Author contributions
Author contributions: N.P., J.R.A., and A.K. designed research; N.P., J.R.A., K.E.S., B.V.A., and A.K. performed research; N.P., J.R.A., K.E.S., and A.K. analyzed data; N.P., J.R.A., and A.K. wrote the paper.
Disclosures
The authors declare no competing financial interests.
This work was supported by the Wings for Life Spinal Cord Research Foundation Grant WFL-US-13/16; by a pilot Grant from the Department of Neurosurgery, Medical College of Wisconsin; and startup funding from Advancing a Healthier Wisconsin Endowment (AHW).
Funding
Wings for Life (Wings for Life Research Foundation)
WFL-US-13/16Advancing a Healthier Wisconsin
Department of Neurosurgery, Medical College of Wisconsin
Other Version
- You are viewing the most recent version of this article.
- previous version (February 25, 2021).
Article usage
In this issue
Use of a Self-Delivering Anti-CCL3 FANA Oligonucleotide as an Innovative Approach to Target Inflammation after Spinal Cord Injury
